1 |
Lundkvist C, Halldin C, Swahn CG, Hall H, Karlsson P, Nakashima Y, et al. [O-methyl- ]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations. Nucl Med Biol 1995;22:905-13
DOI
ScienceOn
|
2 |
Okada T, Fujita M, Shimada S, Sato K, Schloss P, Watanabe Y, Itoh Y, Tohyama M, Nishimura T. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines. Nucl Med Biol 1998;25:53-8
DOI
ScienceOn
|
3 |
Goodman MM, Kilts CD, Keil R, Shi B, Martarello L, Xing D, et al. -labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Nucl Med Biol 2000;27:1-12
DOI
ScienceOn
|
4 |
Zoghbi SS, Shetty HU, Ichise M, Fujita M, Imaizumi M, Liow JS, et al. PET imaging of the dopamine transporter with -FECNT : apolar radiometabolite confounds brain radioligand measurements. J Nucl Med 2006;47:520-7
|
5 |
Dolle F, Emond P, Mavel S, Demphel S, Hinnen F, Mincheva Z, et al. Synthesis, radiosynthesis and in vivo preliminary evaluation of [ ]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET. Bioorg Med Chem 2006;14: 1115-25
DOI
ScienceOn
|
6 |
Chalon S, Hall H, Saba W, Garreau L, Dolle F, Halldin C, et al. Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2betacarbomethoxy- 3beta-( -tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter. J Pharmacol Exp Ther 2006;317:147-52
DOI
ScienceOn
|
7 |
Saba W, Valette H, Schollhorn-Peyronneau MA, Coulon C, Ottaviani M, Chalon S, et al. [ ]LBT-999: a suitable radioligand for investigation of extra-striatal dopamine transporter with PET. Synapse 2007;61:17-23
DOI
ScienceOn
|
8 |
Dolle F, Hinnen F, Emond P, Mavel P, Mincheva Z, Saba W, et al. Radiosynthesis of [ ]LBT-999, a selective radioligand for the visualization of the dopamine transporter with PET. J Label Compd Radiopharm 2006;49:687-98
DOI
ScienceOn
|
9 |
Chaly T, Dhawan V, Kazumata K, Antonini A, Margouleff C, Dahl JR, et al. Radiosynthesis of [ ] N-3-fluoropropyl-2-betacarbomethoxy- -beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography. Nucl Med Biol 1996; 23:999-1004
DOI
ScienceOn
|
10 |
Kim DW, Ahn DS, Oh YH, Lee S, Kil HS, Oh SJ, et al. A new class of reactions catalyzed by protic solvents: Facile fluorination for isotopic labeling of diagnostic molecules. J Am Chem Soc 2006;128:16394-7
DOI
ScienceOn
|
11 |
Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, et al. Dopamine transporter imaging with fluorine- 18-FPCIT and PET. J Nucl Med 1998;39:1521-30
|
12 |
Huang Y, Hwang DR, Narendran R, Sudo Y, Chatterjee R, Bae SA, et al. Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [ ]McN 5652, [ ]ADAM, [ ]DASB, [ ]DAPA, and [ ]AFM. J Cereb Blood Flow Metab 2002;22:1377-98
DOI
|
13 |
Hashimoto K, Inoue O, Suzuki K, Yamasaki T, Kojima M. Synthesis and evaluation of [ ]cyanoimipramine. Int J Rad ApplInstrum [B] 1987;14:587-92
|
14 |
Livni E, Satterlee W, Robey RL, Alt CA, Van Meter EE, Babich JW, et al. Synthesis of [ ]dapoxetine.HCl, a serotonin re-uptake inhibitor: biodistribution in rat and preliminary PET imaging in the monkey. Nucl Med Biol 1994;21:669-75
DOI
ScienceOn
|
15 |
Suehiro M, Scheffel U, Ravert HT, Dannals RF, Wagner HN Jr. [ ](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET. Life Sci 1993;53:883-92
DOI
ScienceOn
|
16 |
Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, et al. Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands. Bioorg Med Chem Lett 2006;16:1297-300
DOI
ScienceOn
|
17 |
Huang Y, Narendran R, Bae SA, Erritzoe D, Guo N, Zhu Z, et al. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [ ]2-[2-dimethylaminomethyl phenylthio)]-5-fluorophenylamine ([ ]AFA). Nucl Med Biol 2004;31:727-38
DOI
ScienceOn
|
18 |
Dannals RF, Ravert HT, Wilson AA, Wagner HN Jr. Synthesis of a selective serotonin uptake inhibitor: [ ]citalopram. Int J Rad Appl Instrum [A] 1990;41:541-43
DOI
ScienceOn
|
19 |
Frost JJ, Rosier AJ, Reich SG, Smith JS, Ehlers MD, Snyder SH, et al. Positron emission tomographic imaging of the dopamine transporter with -WIN 35,428 revelas marked declines in mild Parkinson's disease. Ann Neurol 1993;34:423-31
DOI
ScienceOn
|
20 |
Jagust WJ, Eberling JL, Biegon A, Taylor SE, VanBrocklin HF, Jordan S, et al. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. J Nucl Med 1996;37:1207-1214
|
21 |
Robeson W, Dhawan V, Belakhlef A, Ma Y, Pillai V, Chaly T, et al. Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects. J Nucl Med 2003;44:961-6
|
22 |
Piccini PP. Dopamine transporter: basic aspects and neuroimaging. Mov Disord 2003;18(Suppl 7):S3-8
DOI
ScienceOn
|
23 |
Au WL, Adams JR, Troiano AR, Stoessl AJ. Parkinson's disease: in vivo assessment of disease progression using positron emission tomography. Brain Res Mol Brain Res 2005;134:24-33
DOI
ScienceOn
|
24 |
Neumeyer JL, Wang S, Gao Y, Milius RA, Kula NS, Campbell A, et al. N- Fluoroalkyl analogs of (1R)-2 -carbomethoxy-3 -(4-iodophenyl)-tropane ( -CIT): Radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporter. J Med Chem 1994;37:1558-61
DOI
ScienceOn
|
25 |
Zhu Z, Guo N, Narendran R, Erritzoe D, Ekelund J, Hwang DR, et al. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics. Nucl Med Biol 2004;31:983-94
DOI
ScienceOn
|
26 |
Kim HJ, Im JH, Yang SO, Moon DH, Ryu JS, Bong JK, et al. Imaging and quantitation of dopamine transporters with iodine- 123-IPT in normal and Parkinson's disease subjects. J Nucl Med 1997;38:1703-11
|
27 |
Huang Y, Hwang DR, Bae SA, Sudo Y, Guo N, Zhu Z, et al. Anew positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [ ]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylam ine ([ ]AFM). Nucl Med Biol 2004;31:543-56
DOI
ScienceOn
|
28 |
Suehiro M, Scheffel U, Dannals RF, Wilson AA, Ravert HT, Wagner HN Jr. Synthesis and biodistribution of a new radiotracer for in vivo labeling of serotonin uptake sites by PET, cis-N,N-[ ]dimethyl-3-(2',4'-dichlorophenyl)-indanamine (cis-[ ]DDPI). Int J Rad Appl Instrum B. 1992;19:549-53
DOI
ScienceOn
|
29 |
Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, et al. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993;13:295-309
DOI
ScienceOn
|
30 |
Lee SJ, Oh SJ, Kim JS, Chi DY, Lim KC, Lim SJ, et al. Preclinical studies of [F-18]Fluoropropyl-arbomethoxyIodonortropane (FP-CIT). 2006 World J Nucl Med 2006;5:S38
|
31 |
Lundkvist C, Loc'h C, Halldin C, Bottlaender M, Ottaviani M, Coulon C, et al. Characterization of bromine-76-labeled 5-bromo- 6-nitroquipazine for PET studies of the serotonin transporter. Nucl Med Biol 1999;26:501-507
DOI
ScienceOn
|
32 |
Zea-Ponce Y, Baldwin RM, Stratton MD, Al-Tikriti M, Souffer R, Schauss JM, et al. Radiosynthesis and PET imaging of [N-methyl- ]LY257327 as a tracer for 5-HT transporters. Nucl Med Biol 1997;24:251-54
DOI
ScienceOn
|
33 |
Kung HF, Kung MP, Choi SR. Radiopharmaceuticals for single-photon emission computed tomography brain imaging. Semin Nucl Med 2003;33:2-13
DOI
ScienceOn
|
34 |
Bergstrom KA, Halldin C, Hall H, Lundkvist C, Ginovart N, Swahn CG, et al. In vitro and in vivo characterisation of norbeta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain. Eur J Nucl Med 1997;24:596-601
DOI
|
35 |
Jarkas N, McConathy J, Voll RJ, Goodman MM. Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'- substituted-phenylthio) benzylamines: potential candidates as selective serotonin transporter radioligands. J Med Chem 2005; 48:4254-65
DOI
ScienceOn
|
36 |
Huang Y, Hwang DR, Zhu Z, Bae SA, Guo N, Sudo Y, et al. Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [ ]5-bromo-2-[2-(dimethyl aminomethylphenylsulfanyl)] phenylamine ([ ]DAPA). Nucl Med Biol 2002;29:741-51
DOI
ScienceOn
|
37 |
Lundkvist C, Halldin C, Ginovart N, Swahn CG, Farde L. [ ] beta-CIT-FP is superior to [ ] beta-CIT-FP for quantitation of the dopamine transporter. Nucl Med Biol 1997;24:621-7
DOI
ScienceOn
|
38 |
Vanbilloen HP, Kieffer DM, Cleynhens BJ, Bormans GM, Mortelmans L, Verbruggen AM. Evaluation of -labeled tropanes with alkyl substituents on the 3beta-phenyl ring as potential dopamine transporter tracers. Nucl Med Biol 2006;33: 413-8
DOI
ScienceOn
|
39 |
Aquilonius SM, Bergstrom K, Eckernas SA, Hartvig P, Leenders KL, Lundkvist H, et al. In vivo evaluation of striatal dopamine reuptake sites using -Nomifesin and positron emission tomography. Acta Neurol Scand 1987;76:283-87
DOI
ScienceOn
|
40 |
Scheffel U, Dannals RF, Suehiro M, Ricaurte GA, Carroll FI, Kuhar MJ, et al. Development of PET/SPECT ligands for the serotonin transporter. NIDA Res Monogr 1994;138:111-30
|
41 |
Oya S, Choi SR, Kung MP, Kung HF. 5-Chloro-2-(2'- ((dimethylamino) methyl)-4'-iodophenylthio) benzenamine: a new serotonin transporter ligand. Nucl Med Biol 2007;34:129-39
DOI
ScienceOn
|
42 |
Huang WS, Lee MS, Lin JC, Chen CY, Yang YW, Lin SZ, et al. Usefulness of brain -TRODAT-1 SPET for the evaluation of Parkinson's disease. Eur J Nucl Med Mol Imaging 2004;31:155-61
DOI
|
43 |
Booji J, Hemelaar J, Speelman JD, Bruin K, Janssen A, Royen EA. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [ ]FP-CIT SPECT. J Nucl Med 1999;40:753-61
|
44 |
Suehiro M, Wilson AA, Scheffel U, Dannals RF, Ravert HT, Wagner HN Jr. Radiosynthesis and evaluation of N-(3- [ ]fluoropropyl)paroxetine as a radiotracer for in vivo labeling of serotonin uptake sites by PET. Int J Rad Appl Instrum B 1991;18:791-6
DOI
ScienceOn
|
45 |
Prunier C, Payoux P, Guilloteau D, Chalon S, Giraudeau B, Majorel C, et al. Quantification of dopamine transporter by -PE2I SPECT and the noninvasive Logan graphical method in Parkinson's disease. J Nucl Med 2003;44:663-70
|
46 |
Lasne MC, Pike VW, Turton DR. The radiosynthesis of [N-methyl- ]-sertraline. Int J Rad Appl Instrum [A] 1989;40: 147-51
DOI
ScienceOn
|
47 |
Wilson AA, Ginovart N, Hussey D, Meyer J, Houle S. In vitro and in vivo characterisation of [ ]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. Nucl Med Biol 2002;29:509-15
DOI
ScienceOn
|
48 |
Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents. J Med Chem 2005;48:2559-70
DOI
ScienceOn
|
49 |
Smith DF, Jensen PN, Gee AD, Hansen SB, Danielsen E, Andersen F, et al. PET neuroimaging with [ ]venlafaxine:serotonin uptake inhibition, biodistribution and binding in living pig brain. Eur Neuropsychopharmacol 1997;7:195-200
DOI
ScienceOn
|
50 |
Oya S, Kung MP, Acton PD, Mu M, Hou C, Kung HF. A new single-photon emission computed tomography imaging agent for serotonin transporters: [ ]IDAM, 5-iodo-2-((2-((dimethylamino) methyl)phenyl)thio)benzyl alcohol. J Med Chem 1999;42:333-5
DOI
ScienceOn
|